96 related articles for article (PubMed ID: 6409440)
1. Abnormal responses to the carcinogen 4-nitroquinoline 1-oxide of cultured fibroblasts from patients with dysplastic nevus syndrome and hereditary cutaneous malignant melanoma.
Smith PJ; Greene MH; Adams D; Paterson MC
Carcinogenesis; 1983; 4(7):911-6. PubMed ID: 6409440
[TBL] [Abstract][Full Text] [Related]
2. Abnormal sensitivity to UV-radiation in cultured skin fibroblasts from patients with hereditary cutaneous malignant melanoma and dysplastic nevus syndrome.
Smith PJ; Greene MH; Devlin DA; McKeen EA; Paterson MC
Int J Cancer; 1982 Jul; 30(1):39-45. PubMed ID: 7118297
[TBL] [Abstract][Full Text] [Related]
3. Relationship between sensitivity of cells from patients with hereditary cutaneous malignant melanoma to killing and mutations by 4-nitroquinoline 1-oxide and adduct formation.
Sato K; Howell JN; Greene MH; Maher VM; McCormick JJ
Cancer Res; 1988 Sep; 48(18):5145-50. PubMed ID: 3136916
[TBL] [Abstract][Full Text] [Related]
4. Fibroblasts from patients with hereditary cutaneous malignant melanoma are abnormally sensitive to the mutagenic effect of simulated sunlight and 4-nitroquinoline 1-oxide.
Howell JN; Greene MH; Corner RC; Maher VM; McCormick JJ
Proc Natl Acad Sci U S A; 1984 Feb; 81(4):1179-83. PubMed ID: 6422469
[TBL] [Abstract][Full Text] [Related]
5. Bioreduction of 4-nitroquinoline 1-oxide in dysplastic nevus syndrome fibroblasts.
Mirzayans R; Sabour M; Paterson MC
Mutat Res; 1989 Apr; 225(4):165-9. PubMed ID: 2494449
[TBL] [Abstract][Full Text] [Related]
6. Hypersensitivity to cell killing and faulty repair of 1-beta-D-arabinofuranosylcytosine-detectable sites in human (ataxia-telangiectasia) fibroblasts treated with 4-nitroquinoline 1-oxide.
Mirzayans R; Smith BP; Paterson MC
Cancer Res; 1989 Oct; 49(20):5523-9. PubMed ID: 2507129
[TBL] [Abstract][Full Text] [Related]
7. Alkaline sucrose sedimentation analysis as an indicator of repair capability of xeroderma pigmentosum fibroblasts for 4-nitroquinoline-1-oxide damage.
Walker IG
Carcinogenesis; 1981; 2(8):691-5. PubMed ID: 6793257
[TBL] [Abstract][Full Text] [Related]
8. DNA damage and its repair in human normal or xeroderma pigmentosum fibroblasts treated with 4-nitroquinoline 1-oxide or its 3-methyl derivative.
Mirzayans R; Waters R
Carcinogenesis; 1981; 2(12):1359-62. PubMed ID: 6799219
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous and 4-nitroquinoline 1-oxide-induced G2 chromosome aberrations in lymphoblasts from familial melanoma patients.
Lu GH; Hayward NK; Stanley WS
Cancer Genet Cytogenet; 1989 Jun; 39(2):233-43. PubMed ID: 2502307
[TBL] [Abstract][Full Text] [Related]
10. Chromosomal sensitivity to X-ray irradiation during the G2 phase in lymphocytes of patients with hereditary cutaneous malignant melanoma as compared to healthy controls.
Andersson HC; Lewensohn R; Månsson-Brahme E
Mutat Res; 1999 Mar; 425(1):9-20. PubMed ID: 10082912
[TBL] [Abstract][Full Text] [Related]
11. Hereditary dysplastic nevus syndrome: lymphoid cell ultraviolet hypermutability in association with increased melanoma susceptibility.
Perera MI; Um KI; Greene MH; Waters HL; Bredberg A; Kraemer KH
Cancer Res; 1986 Feb; 46(2):1005-9. PubMed ID: 3940625
[TBL] [Abstract][Full Text] [Related]
12. Lack of correlation between hypersensitivity to cell killing and impaired inhibition of DNA synthesis in ataxia telangiectasia fibroblasts treated with 4-nitroquinoline 1-oxide.
Mirzayans R; Paterson MC
Carcinogenesis; 1991 Jan; 12(1):19-24. PubMed ID: 1899054
[TBL] [Abstract][Full Text] [Related]
13. Enhanced bioreduction of 4-nitroquinoline 1-oxide by cultured ataxia telangiectasia cells.
Mirzayans R; Sabour M; Paterson MC
Carcinogenesis; 1988 Sep; 9(9):1711-5. PubMed ID: 3136948
[TBL] [Abstract][Full Text] [Related]
14. Repair of 4-nitroquinoline-1-oxide-induced DNA damage in normal human cells and cells from classical and variant xeroderma pigmentosum.
Dollery AA; Melvin WT; Keir HM; Harris WJ
Mutat Res; 1983 Feb; 112(1):33-46. PubMed ID: 6402692
[TBL] [Abstract][Full Text] [Related]
15. Ultraviolet mutagenesis in a plasmid vector replicated in lymphoid cells from patient with the melanoma-prone disorder dysplastic nevus syndrome.
Seetharam S; Waters HL; Seidman MM; Kraemer KH
Cancer Res; 1989 Nov; 49(21):5918-21. PubMed ID: 2790806
[TBL] [Abstract][Full Text] [Related]
16. Studies on the metabolism and biological effects of nitropyrene and related nitro-polycyclic aromatic compounds in diploid human fibroblasts.
Maher VM; Patton JD; McCormick JJ
Res Rep Health Eff Inst; 1988 Mar; (17):1-33. PubMed ID: 3269256
[TBL] [Abstract][Full Text] [Related]
17. Unscheduled DNA synthesis induced by 4-nitroquinoline-1-oxide in xeroderma pigmentosum cells and their complementing heterodikaryons.
Tanaka K; Takebe H; Okada Y
Somatic Cell Genet; 1980 Nov; 6(6):739-49. PubMed ID: 6777887
[TBL] [Abstract][Full Text] [Related]
18. Clustered repair of excisable 4-nitroquinoline-1-oxide adducts in a larger fraction of genomic DNA of xeroderma pigmentosum complementation group C cells.
Fujiwara Y
Carcinogenesis; 1989 Oct; 10(10):1777-85. PubMed ID: 2507185
[TBL] [Abstract][Full Text] [Related]
19. 4NQO- or MNNG-resistant variants established from a human cell line, RSb, with high sensitivity to both agents.
Suzuki N
Mutat Res; 1987 May; 178(1):135-41. PubMed ID: 3106797
[TBL] [Abstract][Full Text] [Related]
20. The response to DNA damage induced by 4-nitroquinoline-1-oxide or its 3-methyl derivative in xeroderma pigmentosum fibroblasts belonging to different complementation groups: evidence for different epistasis groups involved in the repair of large adducts in human DNA.
Edwards S; Fielding S; Waters R
Carcinogenesis; 1987 Aug; 8(8):1071-5. PubMed ID: 3111741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
